Working to facilitate rapid translation of scientific discoveries into therapeutics

Speakers

Michael N. Liebman, PhD
Managing Director, Strategic Medicine, Inc, & IPQ Analytics, LLC, USA.

Ernesto Oviedo-Orta, MD, PhD
Clinical Sciences Expert, Novartis Vaccines and Diagnostics,Siena, Italy.

Cees Winnips, MD
Medical Director Europe, Myriad Genetics, Zürich, Switzerland.

Nicholas J. Sarlis, MD, PhD
Vice President and Head of Medical Affairs, Incyte Corporation, USA.

Ulrich Pfeffer
Director, National Cancer Research Institute – IST Genova, Italy.

Ali Cyrus Banan, PhD
Executive Director, Translational Medicine Research, University of South Carolina, School of Medicine, USA.

Godefridus Peters
Chair of PAMM & Prof. Vrije Universiteit Medisch Centrum Amsterdam, EORTC, Belgium.

Theresa T. Pizarro, PhD
Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Mauro Magnani
Dipartimento di Scienze Biomolecolari, Università degli Studi “Carlo Bo” Urbino, Italy.

Thomas Stoehr, PhD
Head, Translational Medicine, Ablynx, Belgium.

Hugo Geerts, MD, PhD
Professor, Perelman School of Medicine, Philadelphia, & In Silico Biosciences, USA.

Wei Wang, MD, PhD, FFPH
Professor, School of Medical Sciences, Edith Cowan University, Australia.

Ivo Gut, PhD
Director, National Genome Analysis Centre (CNAG), Spain.

Enitan Carrol, MD, MRCPCH, FRCPCH
Institute of Infection & Global Health, University of Liverpool, UK.

Erfan Younesi, PhD
Fraunhofer Institute for Algorithms and Scientific Computing SCAI, Department of Bioinformatics, Sankt Augustin, Germany.

Sabrina Mattoli, MD, PhD
Founder and Director, AVAIL GmbH, Switzerland.
Co-founder and Director, Avail Biomedical Research Institute, Switzerland.

Jes S. Lindholt
Professor, Elitary Research Centre of Individualised Medicine in Arterial Diseases (CIMA)
Department of Cardiovascular- and Thoracic Surgery T, University Hospital of Odense, Odense, Denmark.

Istvan Janosi
Managing Director, Planimeter Kft., Budapest, Hungary.

Alexandra Zanin-Zhorov
Senior Director Immunology, Kadmon Research Institute, New York, USA.

John T. Weber
School of Pharmacy and Faculty of Medicine Memorial University of Newfoundland, Canada.

Randall J Cohrs, PhD
Professor, School of Medicine, University of Colorado, Denver, USA.

Imad Abugessaisa
Assistant professor, Unit for Computational Medicine, Department of Medicine Solna, Karolinska Institutet, Sweden.

Fengmin Zhang, PhD, MD
Dean, Basic Medical Science School, Harbin Medical University (HMU), China.

Denise Sonntag
Director, Contract Research, BIOCRATES Life Sciences AG, Innsbruck, Austria.

Antonio Facchiano, MD
Professor, IDI-IRCCS, University Tor Vergata, Rome, Italy.

Zhao-Hua Zhong, PhD
Associated Director, Department of Microbiology, Harbin Medical University, China.

Daniel Wagner, MD
Head of Translational Cardiovascular Research Lab, CRP-Santé, Luxembourg.

Olga GOLUBNITSCHAJA, MD
Professor, Department of Radiology, University of Bonn, Germany.

Gottfried Köhler, PhD
CEO, OnkoTec GmbH, Austria.

Philippe Ancian, PhD
Head of Molecular Immunology & Biomarkers, Transgene, France.

Hüseyin Firat
CEO & President, Firalis SAS, France.

Guus van Dongen
Project leader VU University Medical Imaging Center Amsterdam, NL.

Thomas Joos
Director Strategic Alliances EDI GmbH, Myriad RBM Company Reutlingen, Germany.

Lynn Zieske
VP, Commercial Solutions Singulex, Inc. Alameda, USA.

Xinhua Yin, MD, PhD
Vice Dean, Cardiovascular Hospital, the First Affiliated Hospital, Harbin Medical University, Harbin, China.

2013-2019©European Society for Translational Medicine (EUSTM)

Subscribe to Our Newsletter